Singapore markets close in 3 hours 2 minutes
Straits Times Index
3,310.23 +13.34 (+0.40%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,464.49 +257.36 (+1.41%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,596.73 +2,209.95 (+3.85%) CMC Crypto 200
1,282.40 +11.66 (+0.92%)
TScan Therapeutics, Inc. (TCRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 8.62 |
| Open | 8.76 |
| Bid | 8.60 x 100 |
| Ask | 8.70 x 100 |
| Day's range | 8.55 - 8.81 |
| 52-week range | 1.93 - 9.00 |
| Volume | |
| Avg. volume | 210,698 |
| Market cap | 457.263M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
TScan Therapeutics (TCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%
Key Insights Significantly high institutional ownership implies TScan Therapeutics' stock price is sensitive to their...
© 2024 Yahoo. All rights reserved.